Clinical Trial Update: SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

View source ↗

Summary

This entry reports the completion of the SELECT-LIFE study, a long-term follow-up of semaglutide effects in participants from the SELECT cardiovascular outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Status: COMPLETED